protein arginine deiminase IV inhibitor (Jubilant Therapeutics)

N/A

Report date: 2025/01/26 19:35:15
NME

Base Information

Drug Nameprotein arginine deiminase IV inhibitor (Jubilant Therapeutics)
Drug Alias NameJBI-589
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein-arginine deiminase type-4 inhibitors
TargetsProtein-arginine deiminase type-4
Therapy Area/IndicationsSolid tumoursArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJubilant Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJubilant Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A